Expression of transcription factor AP-2α predicts survival in epithelial ovarian cancer

British Journal of Cancer

Volumn 82, Issue 12, 2000, Pages 1974-1983

  Anttila, M A ^a,c   Kellokoski, J K ^a   Moisio, Ki ^a   Mitchell, P J ^b   Saarikoski, S ^a   Syrjanen K ^a   Kosma, V M ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

AP 2 ; Epithelial ovarian cancer; P21 WAF1; Prognosis

Indexed keywords

ANTIBODY; MESSENGER RNA; PROTEIN P21; TRANSCRIPTION FACTOR AP 2;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL NUCLEUS; CLINICAL FEATURE; CYTOPLASM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

AGED; CARCINOMA; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS;

EID: 0034029198     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Anttila MA, Kosma VM, Hongxiu J, Puolakka J, Juhola M, Saarikoski S and Syrjanen K (1999) p1/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer. Br J Cancer 79: 1870-1878
2. Bar-Eli M (1997) Molecular mechanisms of melanoma metastasis. J Cell Physiol 173: 275-278
3. Batsche E, Muchardt C, Behrens J, Hurst HC and Cremisi C (1998) RB and c-MYC activate expression of the E-Cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol 18: 3647-3658
4. Bosari S, Viale G, Bossi P, Maggioni M, Coggi G, Murray JJ and Lee ACK (1994) Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 86: 681-687
5. Bosher JM, Totty NF, Hsuan JJ, Williams T and Hurst HC (1996) A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 13: 1701-1707
6. Bosher JM, Williams T and Hurst HC (1995) The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci USA 92: 744-747
7. Cancer Committee of the International Federation of Gynecology and Obstetrics (1989) Staging Announcement: FIGO Cancer Committee. Gynecol Oncol 25: 383-385
8. Casey G (1997) The BRCA1 and BRCA2 breast cancer genes. Curr Opin Oncol 9: 88-93
9. Chen Y, Chen CF, Riley DJ, Allred DC, Chen PL, Von Hoff D, Oshorne CK and Lee WH (1995) Ahberrant subcellular localization of BRCA1 in breast cancer. Science 270: 789-791
10. Chiu R, Imagawa M, Imhra RJ, Bockoven JR and Karin M (1987) Multiple cis- and trans-acting elements mediate the transcriptional response to phorbol esters. Nature 329: 648-651
11. Cox DR (1999) Regression models and life tables with discussion. J Stat Soc B 34: 187-192
12. Foulkes WD, Ragoussis J, Stamp GWH, Allan GJ and Trowsdale J (1993) Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer 67: 551-559
13. Gilbertson RJ, Perry RH, Kelly PJ, Pearson AD and Lunec J (1997) Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res 57: 3272-3280
14. Goldman SC, Chen CY, Lansing TJ, Gilmer TM and Kastan MB (1996) The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization. Am J Pathol 148: 1381-1385
15. Hennig G, Lowrick O, Birchmeier W and Behrens J (1996) Mechanisms identified in the transcriptional control of epithelial gene expression. J Biol Chem 271: 595-602
16. Hietala KA, Kosma VM, Syrjanen KJ, Syrjanen SM and Kellokoski JK (1997) Correlation of MIB-1 antigen expression with transcription factors Skn-1, Oct-1, AP-2, and HPV type in cervical intraepithelial neoplasia. J Pathol 183: 305-310
17. Huhtala P, Chow LT and Tryggvason K (1990) Structure of the human type IV collagenase gene. J Biol Chem 265: 11077-11082
18. Hyman SE, Comb M, Pearlberg J and Goodman HM (1989) An AP-2 element acts synenergistically with the cyclic AMP- and phorbol ester-inducible enhancer of the human proenkephalin gene. Mol Cell Biol 9: 321-324
19. Imagawa M, Chiu R and Karin M (1987) Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51: 251-260
20. Ito Y, Kobayashi T, Takeda T, Komoike Y, Wakasugi E, Tamaki Y, Tsujimoto M, Matsuura N and Monden M (1996) Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues. Br J Cancer 74: 1269-1274
21. Jean D, Gershenwald JE, Huang S, Luca M, Hudson MJ, Tainsky MA and Bar-Eli M (1998) Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells. J Biol Chem 273: 16501-16508
22. Kannan P, Buettner R, Chiao PJ, Yim SO, Sarkiss M and Tainsky MA (1994) N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. Genes Dev 8: 1258-1269
23. Kaplan EL and Meier P (1958) Non-parametric estimation from incomplete observation. J Am Stat Assoc 53: 457-481
24. Karin M and Hunter T (1995) Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr Biol 7: 747-757
25. Karjalainen JM, Kellokoski JK, Eskelinen MJ, Alhava EM and Kosma VM (1998) Downregulation of transcription factor AP-2 predicts poor survival in stage 1 cutaneous malignant melanoma. J Clin Oncol 16: 3584-3591
26. Kleijn M, Scheper GC, Voorma HO and Thomas AAM (1998) Regulation of translation initiation factors by signal transduction. Eur J Biochem 253: 531-544
27. Leask A, Byrne C and Fuchs E (1991) Transcription factor AP-2 and its role in epidermal-spesific gene expression. Proc Natl Acad Sci USA 88: 7948-7952
28. Lee W, Haslinger A, Karin M and Tjian R (1987) Activation of transciption by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature 325: 368-372
29. Luscher B, Mitchell PJ, Williams T and Tjian R (1989) Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. Genes Dev 3: 1507-1517
30. Mitchell PJ, Wang C and Tjian R (1987) Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell 50: 847-861
31. Mitchell PJ, Timmons PM, Hebert JM, Rigby PW and Tjian R (1991) Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev 5: 105-119
32. Moll UM, Riou G and Levine AJ (1992) Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA 89: 7262-7266
33. Ropponen KM, Kellokoski JK, Lipponen PK, Pietiläinen T, Eskelinen MJ, Alhava EM and Kosma VM (1999) p21/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis. Br J Cancer, 81: 133-140
34. Sato M, Saito B, Morita R, Koi S, Lee JH and Nakamura Y (1991) Allelotype of human ovarian cancer. Cancer Res 51: 5118-5122
35. Serov SF, Scully R and Sobin LH (1973) Histological typing of ovarian tumours International Histological Classification of Tumours no. 9. Geneva: WHO
36. Soong R, Knowles S, Williams KE, Hammond IG, Wysocki SJ and Iacopetta BJ (1996) Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma. Br J Cancer 74: 562-567
37. Sperry A, Jin L and Lloyd RV (1996) Microwave treatment enhances detection of RNA and DNA by in sity hybridization. Diagn Mol Pathol 5: 291-296
38. Subramaniam M, Hefferan TE, Tau K, Peus D, Pittelkow M, Jalal S, Riggs BL, Roche P and Spelsberg TC (1998) Tissue, cell type, and breast cancer stage-specific expression of a TGF-beta inducible early transcription factor gene. J Cell Biochem 68: 226-236
39. Sugg SL, Ezzat S, Rosen IB, Freeman JL and Asa SL (1998) Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metabol 83: 4116-4122
40. Sun XF, Carstensen JM, Zhang H, Stal O, Wingren S, Hatschek T and Nordenskjöld B (1992) Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 340: 1369-1373
41. Sun X, Shimizu H and Yamamoto K (1995) Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression. Mol Cell Biol 15: 4489-4496
42. Sundfeldt K, Ivarsson K, Carlsson M, Enerback S, Janson PO, Brannstrom M and Hedin L (1999) The expression of CTAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPbeta during epithelial tumour progression. Br J Cancer 19: 1240-1248
43. Turner BC, Zhang J, Gumbs AA, Maher MG, Kaplan L, Carter D, Glazer PM, Hurst HC, Haffty BG and Williams T (1998) Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res 58: 5466-5472
44. Wakasugi E, Kobayashi T, Tamaki Y, Ito Y, Miyashiro I, Komoike Y, Takeda T, Shin E, Takatsuka Y, Kikkawa N, Monden T and Monden M (1997) p21 (Waf1/Cip1) and p53 protein expression in breast cancer. Am J Clin Pathol 107: 684-691
45. William T, Admon A, Luscher B and Tjian R (1988) Cloning and expression of AP-2, a cell-type-speCific transcription factor that activates inducible enhancer elements. Genes Dev 2: 1557-1569
46. Williamsnn JA, Bosher JM, Skinner A, Sheer D, Williams T and Hurst HC (1996) Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors. Genomics 35: 262-264
47. Winning RS, Shea LJ, Marcus SJ and Sargent TD (1991) Developmental regulation of transcription factor AP-2 during Xenopus laevis embryogenesis. Nucleic Acid Res 19: 3709-3714
48. Zeng YX, Somasundaram K and el-Deiry WS (1997) AP2 inhibits cancer cell growth and activates p21 WAF1/CIP1 expression. Nat Genet 15: 78-82